furosemide has been researched along with calcitriol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hirano, T; Kozaki, M; Oka, K; Tamaki, T; Toyoshima, Y | 1 |
| Bushinsky, DA; Coe, FL; Favus, MJ; Langman, CB | 1 |
| Gottleib, S; Rude, RK; Sharp, CF; Singer, FR | 1 |
| Coto, T; Fernández, P; Martínez, V; Muñoz, R; Ordóñez, FA; Rodríguez, J; Santos, F | 1 |
| Bernardini, M; Boldrini, A; Bottone, U; Coccoli, L; Cuttano, A; Ghirri, P; Pellegrinetti, G; Riparbelli, C; Vuerich, M | 1 |
| Cabeza, JM; Crespo, M; Fernández, P; Gómez, C; Rey, C; Rodríguez, J; Santos, F | 1 |
| Andreasen, F; Heickendorff, L; Mosekilde, L; Rejnmark, L; Vestergaard, P | 1 |
| Deshpande, MM | 1 |
| Ciccone, S; De Sanctis, V; Fiscina, B | 1 |
| Azizi, M; Blanchard, A; Brailly-Tabard, S; Chanson, P; Gauci, C; Kamenický, P; Letierce, A; Lombès, M; Prié, D; Salenave, S; Souberbielle, JC | 1 |
| Cheng, CJ; Chu, SM; Lien, R; Lin, SH; Shih, IS; Tseng, MH | 1 |
| Addissie, B; Kumar, R; Martens, P | 1 |
| Bilancio, G; Cirillo, C; Cirillo, M | 1 |
1 review(s) available for furosemide and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for furosemide and calcitriol
| Article | Year |
|---|---|
Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?
Topics: Acromegaly; Adult; Aged; Calcitriol; Calcium, Dietary; Diuretics; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Furosemide; Human Growth Hormone; Humans; Hypercalciuria; Insulin-Like Growth Factor I; Kidney Tubules, Distal; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphates; Serum Albumin; Sodium Chloride, Dietary; Vitamin D | 2012 |
16 other study(ies) available for furosemide and calcitriol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Promotion of lymphocyte blastogenesis by hemodialysate of chronic renal failure.
Topics: Allopurinol; Anabolic Agents; Androstanols; Calcitriol; Cells, Cultured; Concanavalin A; Creatinine; DNA Replication; Female; Furosemide; Humans; Kidney Failure, Chronic; Lectins; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Nifedipine; Reference Values; Renal Dialysis; Thymidine; Time Factors | 1992 |
Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption.
Topics: Animals; Calcitriol; Calcium; Diuresis; Furosemide; Homeostasis; Intestinal Absorption; Magnesium; Male; Phosphorus; Rats; Time Factors | 1986 |
Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
Topics: Adenocarcinoma; Adult; Calcitriol; Cyclic AMP; Dinoprostone; Female; Furosemide; Humans; Hypercalcemia; Kidney Neoplasms; Parathyroid Hormone; Phosphorus; Prostaglandins E | 1982 |
Rat models of normocalcemic hypercalciuria of different pathogenic mechanisms.
Topics: Animals; Calcitriol; Calcium; Creatinine; Disease Models, Animal; Female; Furosemide; Parathyroid Hormone; Rats; Rats, Sprague-Dawley | 1998 |
Symptomatic hypercalcemia in the first months of life: calcium-regulating hormones and treatment.
Topics: Adrenal Cortex Hormones; Calcifediol; Calcitonin; Calcitriol; Calcium, Dietary; Diuretics; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism; Infant; Infant, Newborn; Male; Parathyroid Hormone; Vitamin D | 1999 |
Influence of three different types of hypercalciuria on bone. An experimental study.
Topics: Absorptiometry, Photon; Administration, Oral; Ammonium Chloride; Animals; Bone Density; Calcium; Diuretics; Female; Furosemide; Injections, Intraperitoneal; Rats; Rats, Sprague-Dawley; Vitamin D | 1999 |
Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover.
Topics: Aged; Aged, 80 and over; Biomarkers; Bone Density; Bone Remodeling; Calcitriol; Calcium; Cross-Sectional Studies; Diuretics; Female; Furosemide; Humans; Linear Models; Middle Aged; Parathyroid Hormone; Postmenopause; Statistics, Nonparametric; Time Factors | 2005 |
Iatrogenic hypercalcaemia--a case report.
Topics: Bone Density Conservation Agents; Calcitonin; Calcitriol; Calcium; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Hypercalcemia; Iatrogenic Disease; Low Back Pain; Middle Aged | 2009 |
Severe hypercalcemia in a patient treated for hypoparathyroidism with calcitriol.
Topics: Adolescent; Calcitonin; Calcitriol; Furosemide; Humans; Hypercalcemia; Hypoparathyroidism; Male; Prednisone | 2010 |
An infant with multiple subcutaneous nodules, hypercalcemia, and nephrocalcinosis.
Topics: Biomarkers; Calcitriol; Calcium; Diuretics; Fat Necrosis; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Infant; Male; Nephrocalcinosis; Parathyroid Hormone; Potassium Citrate; Skin; Subcutaneous Fat; Treatment Outcome | 2013 |
Follicular lymphoma presenting with hypercalcaemia: an unusual mechanism of hypercalcaemia.
Topics: Aged; Bone Density Conservation Agents; Calcitonin; Chemokines; Cytokines; Diphosphonates; Diuretics; Female; Furosemide; Humans; Hypercalcemia; Imidazoles; Lymphoma, Follicular; Neoplasm Staging; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parotid Gland; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Sodium Chloride; Vitamin D; Zoledronic Acid | 2015 |
Reversible vascular calcifications associated with hypervitaminosis D.
Topics: Biomarkers; Calcium; Cholecalciferol; Diuretics; Fluid Therapy; Furosemide; Glucocorticoids; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Nutrition Disorders; Omeprazole; Prednisone; Proton Pump Inhibitors; Remission Induction; Sodium Chloride; Time Factors; Treatment Outcome; Up-Regulation; Vascular Calcification; Vitamin D | 2016 |